ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,341Medicare Part D Prescriptions Filled, Including Refills

Rank: 496 out of 3734

$575K Total Retail Price of All Prescriptions

Rank: 527 out of 3734

409 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,365 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 406 291 1 1
LEVOTHYROXINE SODIUM 386 334 2 2
SERTRALINE HCL 360 315 3 18
OMEPRAZOLE 333 271 4 4
FUROSEMIDE 287 266 5 7
HYDROCODONE-ACETAMINOPHEN 275 226 S3 6 12
METFORMIN HCL 249 164 7 8
METOPROLOL TARTRATE 243 222 8 6
AMLODIPINE BESYLATE 234 211 9 5
LISINOPRIL 195 170 10 3
POTASSIUM CHLORIDE 162 150 11 19
ATENOLOL 147 113 12 13
WARFARIN SODIUM 142 127 13 10
OXYCODONE-ACETAMINOPHEN 140 103 S2 14 51
GABAPENTIN 115 64 15 17
TAMSULOSIN HCL 114 111 16 29
CARVEDILOL 113 92 17 30
ADVAIR DISKUS 111 66 18 35
GLYBURIDE 110 95 R 19 64
DIGOXIN 108 104 20 43
CELEBREX 98 79 21 69
VENLAFAXINE HCL ER 96 55 22 84
TRAMADOL HCL 95 56 23 20
ZOLPIDEM TARTRATE 92 82 24 24
POLYETHYLENE GLYCOL 3350 92 85 24 53
ALLOPURINOL 85 72 26 33
RANITIDINE HCL 85 60 26 32
NEXIUM 85 55 26 36
PRAVASTATIN SODIUM 84 75 29 15
DONEPEZIL HCL 76 76 30 25
CLOPIDOGREL 75 67 31 23
AZITHROMYCIN 74 54 32 38
PANTOPRAZOLE SODIUM 73 67 33 22
OXYCONTIN 72 41 S2 34 121
MIRTAZAPINE 70 64 35 45
VESICARE 69 67 36 157
ISOSORBIDE MONONITRATE ER 67 55 37 34
DIOVAN 66 43 38 31
TRAZODONE HCL 66 64 38 49
TRIAMTERENE-HCTZ 65 33 40 73
PREDNISONE 64 50 41 42
PAROXETINE HCL 64 64 41 59
HYDROCHLOROTHIAZIDE 63 58 43 9
NOVOLOG FLEXPEN 63 43 43 218
FINASTERIDE 63 63 43 88
ALBUTEROL SULFATE 61 52 46 128
KLOR-CON M20 60 55 47 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 39 48 27
CYMBALTA 56 47 49 67
CIPROFLOXACIN HCL 56 53 49 77
JANUVIA 56 44 49 50
ALENDRONATE SODIUM 56 49 49 26
ESCITALOPRAM OXALATE 54 33 53 68
SYNTHROID 54 41 53 47
METOCLOPRAMIDE HCL 53 34 55 158
ATORVASTATIN CALCIUM 53 44 55 11
FLUOXETINE HCL 53 45 55 61
FENTANYL 52 41 S2 58 65
QUINAPRIL HCL 52 39 58 74
LANTUS SOLOSTAR 52 28 58 102
CITALOPRAM HBR 50 41 61 16
METOPROLOL SUCCINATE 50 50 61 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.